BCTX logo

Briacell Therapeutics Corp. Common Shares


BCTX: BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in advanced metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advanced-stage breast cancer by matching the patient's HLA type.


Show BCTX Financials

Consumer Interest
SEC Filings

Recent trades of BCTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by BCTX's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of BCTX in WallStreetBets Daily Discussion


Recent insights relating to BCTX

CNBC Recommendations

Recent picks made for BCTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BCTX

Corporate Flights

Flights by private jets registered to BCTX